Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD
This study is investigating a new medical device called the reSept ASD Occluder. This device is designed to treat a type of heart condition known as secundum Atrial Septal Defect (ASD), which is essentially a hole in the wall separating the upper chambers of the heart. The study aims to find out if this new device is both safe to use and effective at closing these holes. Researchers will compare its performance against devices already approved for this purpose. The goal is to provide a new option for patients whose doctors believe their ASD needs treatment, helping to improve their heart health.
At a glance
What is this study about?
This research is a study about a new way to treat a common heart condition in children and adults called a secundum Atrial Septal Defect, or ASD. Imagine your heart has four main rooms. An ASD is like having a small hole in the wall between the two upper rooms. If this hole is significant, it can make your heart work harder than it should.
The study is testing a new device called the reSept ASD Occluder. This device is designed to close this hole in the heart without needing open-heart surgery. Doctors will guide the device through a small tube (catheter) to the heart and position it to seal the hole. The main goals are to make sure the device is safe for patients and that it successfully closes the ASD, helping the heart to function better.
Researchers will carefully watch patients who receive this device and compare how well it works and how safe it is compared to treatments already available and approved. This type of study helps doctors understand if new treatments are a good option for future patients with this heart condition.
Key takeaways
- Tests a new device for 'holes in the heart' (secundum ASD).
- Aims to check if the new device is safe and works well.
- Compares its results to existing treatments.
- Requires taking aspirin daily for 6 months after the procedure.
- Not suitable for pregnant individuals or those with other severe heart conditions.
Who may be eligible?
To join this study, participants generally need to be under 85 years old and weigh at least 15 kg (about 33 pounds). Both men and women can take part. Crucially, you must have a secundum ASD that your doctor believes needs treatment and is between 5 to 19 mm wide when first checked, and between 8 to 22 mm at the time of the procedure.
There are also some specific medical requirements, such as having enough healthy heart tissue around the hole for the device to attach properly without affecting other important parts of the heart. You must also be able to take certain medications, like a daily low-dose aspirin, for 6 months after the procedure, and a blood thinner called Heparin during the procedure itself.
You cannot join if you are pregnant, have other severe heart valve problems, very high blood pressure in your lungs, or other serious heart conditions like a recent heart attack or blood clots. Everyone joining, or their parents if they are minors, must be willing to give permission and follow the study instructions.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you between 0 and 84 years old?
- Do you weigh at least 15 kg (about 33 pounds)?
- Has your doctor identified a secundum ASD that needs treatment?
- Can you take low-dose aspirin daily for 6 months after the procedure?
- Are you not pregnant (if applicable) and do not have other serious heart problems?
- Are you willing and able to follow the study instructions?
What does participation involve?
If you decide to take part, you will receive the reSept ASD Occluder device during a medical procedure. Before, during, and after the procedure, you'll have various check-ups and tests, likely including heart scans (echos). You will need to take a low dose of aspirin daily for six months following the procedure. You'll also be given Heparin, a blood thinner, during the procedure itself. The research team will regularly check how you are doing to make sure the device is working well and that you are recovering safely. The total duration of follow-up for this study is not specified in detail, but it involves monitoring for at least 6 months after the procedure.
Potential risks and benefits
Locations (32)
- University of Alabama at BirminghamVerified postcodeBirmingham, United States
- Children's Hospital of Los AngelesVerified postcodeLos Angeles, United States
- Los Robles Regional Medical CenterVerified postcodeThousand Oaks, United States
- Children's Hospital ColoradoVerified postcodeAurora, United States
- Yale UniversityVerified postcodeNew Haven, United States
- Joe DiMaggio Children's Hospital/Memorial Healthcare SystemVerified postcodeHollywood, United States
- Children's Healthcare of AtlantaVerified postcodeAtlanta, United States
- Advocate Children's HospitalVerified postcodeOak Lawn, United States
- Riley Hospital for ChildrenVerified postcodeIndianapolis, United States
- Boston Children's HospitalVerified postcodeBoston, United States
- University of MichiganVerified postcodeAnn Arbor, United States
- Children's Hospital of MichiganVerified postcodeDetroit, United States
Common questions
What is an ASD?
An ASD is a 'hole' in the wall between the two upper chambers of your heart. In this study, we're looking at a specific type called secundum ASD.
What is the reSept ASD Occluder?
It's a new medical device designed to close the hole in your heart without the need for open-heart surgery.
How long will I need to be in the study?
You'll be monitored for at least 6 months after the device is put in, which includes taking daily aspirin during this time.
Will this device be approved for everyone?
This study is helping us find out if the device is safe and effective enough to eventually be available more widely. It's not yet generally approved.
Can I leave the study if I change my mind?
Yes, you can choose to leave the study at any time without it affecting your normal medical care.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.